Physician profile
Matthew Davis Mccarty
NPI 1386486744
$3,406.31
in general payments reported to CMS, 2019-2025
10 companies · $1,998 in 2025
The $1,998 reported for 2025 was more than what 99% of Public Medicine providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,408 · 2025: $1,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,406.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,510.50 | 2024-2025 | Citrefix, Variax, Prostep Mica |
| Kerecis Limited | $554.88 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Amgen INC. | $370.37 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $293.51 | 2024-2025 | Stravix, Grafix |
| Bone Support INC. | $275.97 | 2025 | Cerament G, Ceramentbone Void Filler |
| Flower Orthopedics Coporation | $128.07 | 2025 | |
| Bioventus LLC | $123.74 | 2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $85.32 | 2024 | Truelok Evo |
| Kuros Biosciences USA, INC | $48.33 | 2025 | Magnetos |
| Acera Surgical, INC. | $15.62 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.